Grupo Mateus (B3: GMAT3) revenue
Grupo Mateus reported revenue of BRL 38,424m for fiscal 2025, 19.8% more than in fiscal 2024 (BRL 32,085m). Since fiscal 2019 its revenue has grown by 378.2%, an average growth of 29.8% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | BRL 38,424m | +19.8% | BRL 2,261m | 5.9% |
| 2024 | BRL 32,085m | +19.8% | BRL 2,091m | 6.5% |
| 2023 | BRL 26,774m | +23.0% | BRL 1,683m | 6.3% |
| 2022 | BRL 21,768m | +37.1% | BRL 1,365m | 6.3% |
| 2021 | BRL 15,877m | +28.1% | BRL 916.2m | 5.8% |
| 2020 | BRL 12,397m | +54.3% | BRL 869.7m | 7.0% |
| 2019 | BRL 8,036m | — | BRL 461.4m | 5.7% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the revenue of Grupo Mateus
- How much revenue did Grupo Mateus make in fiscal 2025?
- Grupo Mateus reported revenue of BRL 38,424m for fiscal 2025, compared with BRL 32,085m in fiscal 2024.
- How much has the revenue of Grupo Mateus grown?
- Between fiscal 2019 and fiscal 2025 it went from BRL 8,036m to BRL 38,424m: 378.2% more, an average growth of 29.8% a year.
- What was the best year for revenue at Grupo Mateus?
- Of its last 7 fiscal years, fiscal 2025, with BRL 38,424m.
- Where do the figures for Grupo Mateus come from?
- From the annual financial statements (DFP) that Grupo Mateus files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual financial statements (DFP) that Grupo Mateus files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Grupo Mateus: the Grupo Mateus page · annual accounts · net income.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.